It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2015.
2015 | Mumbai, Maharashtra, India | ActiveSisal-Hem Pharmaceutical Private Limited, a active private limited company, was established on 16 May 2015 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900MH2015PTC264557. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Supriya Sanjay Mane (Director), Pratik Prakash Patil (Director), Abhilash Prakash Patil (Director). Past directors included Sagar Bapuso Nichite, Umesh Mahipati Gaikwad, Pratik Prakash Patil. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-2-2. Plot 12, Sector 17, Mumbai Co. Op. Hsg Socity, Vashi, Mumbai, Maharashtra, 400703.
U74900MH2015PTC264557
264557
16 May 2015
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sisal-Hem Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Supriya Sanjay Mane | Director | 16 May 2015 | Current |
| Pratik Prakash Patil | Director | 11 May 2018 | Current |
| Abhilash Prakash Patil | Director | 16 May 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 19 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 07 May 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sisal-Hem Pharmaceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Sisal-Hem Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sisal-Hem Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sisal-Hem Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sisal-Hem Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sisal-Hem Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Sisal-Hem Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Pratik Prakash Patil was appointed as a Director was appointed as a Director on 11 May 2018 & has been associated with this company since 7 years 6 months . was documented.
Supriya Sanjay Mane was appointed as a Director was appointed as a Director on 16 May 2015 & has been associated with this company since 10 years 6 months . was recorded as a recent event.
Progress on Abhilash Prakash Patil was appointed as a Director was appointed as a Director on 16 May 2015 & has been associated with this company since 10 years 6 months . was documented.
Sisal-Hem Pharmaceutical Private Limited was registered on 16 May 2015 with Roc Mumbai & aged 10 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Sisal-Hem Pharmaceutical Private Limited is U74900MH2015PTC264557.
Sisal-Hem Pharmaceutical Private Limited is headquartered at C-2-2. Plot 12, Sector 17, Mumbai Co. Op. Hsg Socity, Vashi, Mumbai, Maharashtra, 400703.
Sisal-Hem Pharmaceutical Private Limited was incorporated on 16 May 2015.
The current directors of Sisal-Hem Pharmaceutical Private Limited are
The primary industry of Sisal-Hem Pharmaceutical Private Limited is Trade.
Sisal-Hem Pharmaceutical Private Limited is unlisted.
The authorized capital of Sisal-Hem Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sisal-Hem Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX